Investigation of influence of anti-thyroid drug discontinuation time on I-131 biokinetics in patients with benign thyroid disease

dc.creator	Topić-Vučenović, Valentina
dc.creator	Vučićević, Katarina
dc.creator	Rajkovača, Zvezdana
dc.creator	Stanimirović, D.
dc.creator	Vuleta, Goran
dc.creator	Jelić, D.
dc.creator	Miljković, Branislava
dc.date.accessioned	2019-09-02T12:00:34Z
dc.date.available	2019-09-02T12:00:34Z
dc.date.issued	2017
dc.identifier.issn	1619-7070
dc.identifier.uri	https://farfar.pharmacy.bg.ac.rs/handle/123456789/2924
dc.publisher	Springer, New York
dc.rights	restrictedAccess
dc.source	European Journal of Nuclear Medicine and Molecular Imaging
dc.title	Investigation of influence of anti-thyroid drug discontinuation time on I-131 biokinetics in patients with benign thyroid disease	en
dc.type	conferenceObject
dc.rights.license	ARR
dcterms.abstract	Топић-Вученовић, Валентина; Вулета, Горан; Миљковић, Бранислава; Јелић, Д.; Рајковача, Звездана; Вучићевић, Катарина; Станимировић, Д.;
dc.citation.volume	44
dc.citation.issue	Supplement 2
dc.citation.spage	S809
dc.citation.epage	S809
dc.citation.other	44: -
dc.citation.rank	aM21
dc.description.other	Annual Congress of the European Association of Nuclear Medicine October 21 – 25, 2017 Vienna, Austria
dc.identifier.wos	000455019402636
dc.identifier.doi	10.1007/s00259-017-3822-1
dc.type.version	publishedVersion